Overview
Healios K.K. is a biotechnology company based in Japan, specializing in the field of regenerative medicine. The company primarily focuses on developing therapies using somatic stem cells, including induced pluripotent stem cells (iPSCs). One of the key projects of Healios K.K. is the development of treatments for age-related macular degeneration (AMD) using retinal pigment epithelial (RPE) cells derived from iPSCs. Another significant area of research for Healios involves treating ischemic stroke victims with stem cell therapies aimed at aiding recovery through neuroregeneration. These innovative projects position Healios K.K. at the forefront of developing novel therapeutic approaches that could potentially revolutionize treatment paradigms in areas with significant unmet medical needs.
Quality, Value, Momentum Scores
This card shows the Quality, Value, and Momentum scores for the company
Income Statement: Revenue, Operating Income, Net Income
- The revenue for Healios K.K. as of June 30, 2025 is 112.00 MM.
- The operating income for Healios K.K. as of June 30, 2025 is -3,091.00 MM.
- The net income for Healios K.K. as of June 30, 2025 is -5,987.00 MM.
| Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
| 2025-06-30 | 112.00 | -3,091.00 | -5,987.00 |
| 2025-03-31 | 588.00 | -2,543.00 | -4,373.00 |
| 2024-12-31 | 560.00 | -2,848.00 | -4,235.00 |
| 2024-09-30 | 549.00 | -3,058.00 | -6,222.00 |
| 2024-06-30 | 521.00 | -3,158.00 | -5,389.00 |
| 2024-03-31 | 124.00 | -3,542.00 | -5,515.00 |
| 2023-12-31 | 121.00 | -3,381.00 | -3,823.00 |
| 2023-09-30 | 174.00 | -3,350.00 | -3,305.00 |
| 2023-06-30 | 176.00 | -3,647.00 | -3,301.00 |
| 2023-03-31 | 86.00 | -4,617.00 | -4,441.00 |
| 2022-12-31 | 90.00 | -5,157.00 | -5,169.00 |
| 2022-09-30 | 41.00 | -5,613.00 | -5,172.00 |
| 2022-06-30 | 43.00 | -6,000.00 | -6,278.00 |
| 2022-03-31 | 43.00 | -5,402.00 | -5,341.00 |
| 2021-12-31 | 41.00 | -5,379.00 | -4,910.00 |
| 2021-09-30 | 36.00 | -5,143.00 | -5,192.00 |
| 2021-06-30 | 33.00 | -4,792.00 | -4,796.00 |
| 2021-03-31 | 29.00 | -4,672.00 | -5,278.00 |
| 2020-12-31 | 27.00 | -4,197.00 | -5,512.00 |
Income Statement: EPS
| Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
| 2025-06-30 | ||
| 2025-03-31 | ||
| 2024-12-31 | -47.87 | -47.86 |
| 2024-09-30 | -73.56 | -73.56 |
| 2024-06-30 | -67.71 | -67.71 |
| 2024-03-31 | -75.57 | -75.58 |
| 2023-12-31 | -56.22 | -56.22 |
| 2023-09-30 | -51.12 | -51.12 |
| 2023-06-30 | -53.90 | -53.90 |
| 2023-03-31 | -75.13 | -75.12 |
| 2022-12-31 | -90.67 | -90.67 |
| 2022-09-30 | -93.18 | -107.61 |
| 2022-06-30 | -115.58 | -119.62 |
| 2022-03-31 | -99.90 | -107.65 |
| 2021-12-31 | -93.36 | -99.52 |
| 2021-09-30 | -100.42 | -100.44 |
| 2021-06-30 | -92.94 | -104.19 |
| 2021-03-31 | -102.46 | -109.98 |
| 2020-12-31 | -107.20 | -107.20 |
Cash Flow: Operations, Investing, Financing
- The cash from operating activities for Healios K.K. as of June 30, 2025 is -2,296.00 MM.
- The cash from investing activities for Healios K.K. as of June 30, 2025 is -1,540.00 MM.
- The cash from financing activities for Healios K.K. as of June 30, 2025 is 1,323.00 MM.
| Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
| 2025-06-30 | -2,296.00 | -1,540.00 | 1,323.00 |
| 2025-03-31 | -1,964.00 | -1,332.00 | 752.00 |
| 2024-12-31 | -1,817.00 | -1,418.00 | 77.00 |
| 2024-09-30 | -2,317.00 | -673.00 | -2,001.00 |
| 2024-06-30 | -2,755.00 | -1,225.00 | 5,779.00 |
| 2024-03-31 | -2,759.00 | -1,006.00 | 4,488.00 |
| 2023-12-31 | -2,822.00 | -1,121.00 | 3,337.00 |
| 2023-09-30 | -2,464.00 | -1,128.00 | 6,106.00 |
| 2023-06-30 | -3,198.00 | -649.00 | -1,529.00 |
| 2023-03-31 | -3,914.00 | -1,116.00 | -1,438.00 |
| 2022-12-31 | -4,601.00 | -909.00 | -2,502.00 |
| 2022-09-30 | -5,691.00 | -996.00 | -3,317.00 |
| 2022-06-30 | -5,478.00 | -998.00 | 7,304.00 |
| 2022-03-31 | -5,144.00 | -692.00 | 7,014.00 |
| 2021-12-31 | -5,089.00 | -736.00 | 6,988.00 |
| 2021-09-30 | -4,539.00 | -638.00 | 7,308.00 |
| 2021-06-30 | -4,255.00 | -657.00 | 719.00 |
| 2021-03-31 | -4,392.00 | -1,440.00 | 709.00 |
| 2020-12-31 | -3,945.00 | -1,216.00 | 803.00 |
Valuation Metrics : PE, PriceToBook, PriceToTBV
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
| Period End (TTM) | p/e | P/Book | P/TBV |
| 2025-06-30 | |||
| 2025-03-31 | |||
| 2024-12-31 | |||
| 2024-09-30 | |||
| 2024-06-30 | |||
| 2024-03-31 | |||
| 2023-12-31 | |||
| 2023-09-30 | |||
| 2023-06-30 | |||
| 2023-03-31 | |||
| 2022-12-31 | |||
| 2022-09-30 | |||
| 2022-06-30 | |||
| 2022-03-31 | |||
| 2021-12-31 | |||
| 2021-09-30 | |||
| 2021-06-30 | |||
| 2021-03-31 | |||
| 2020-12-31 |
Valuation Metrics : EBitToEv, EBit3YrAvgToEv
| Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
| 2025-06-30 | ||
| 2025-03-31 | ||
| 2024-12-31 | ||
| 2024-09-30 | ||
| 2024-06-30 | ||
| 2024-03-31 | ||
| 2023-12-31 | ||
| 2023-09-30 | ||
| 2023-06-30 | ||
| 2023-03-31 | ||
| 2022-12-31 | ||
| 2022-09-30 | ||
| 2022-06-30 | ||
| 2022-03-31 | ||
| 2021-12-31 | ||
| 2021-09-30 | ||
| 2021-06-30 | ||
| 2021-03-31 | ||
| 2020-12-31 |
Management Effectiveness
- The roa for Healios K.K. as of June 30, 2025 is -0.25.
- The roe for Healios K.K. as of June 30, 2025 is -1.34.
- The roic for Healios K.K. as of June 30, 2025 is -0.95.
- The croic for Healios K.K. as of June 30, 2025 is -0.56.
- The ocroic for Healios K.K. as of June 30, 2025 is -0.43.
| Period End (TTM) | ROA | ROE | ROIC | CROIC | OCROIC |
| 2025-06-30 | -0.25 | -1.34 | -0.95 | -0.56 | -0.43 |
| 2025-03-31 | -0.26 | -1.14 | -0.89 | -0.64 | -0.38 |
| 2024-12-31 | -0.41 | -1.61 | -0.80 | -0.65 | -0.30 |
| 2024-09-30 | -0.30 | -0.96 | -0.58 | 0.21 | -0.29 |
| 2024-06-30 | -1.43 | ||||
| 2024-03-31 | -0.87 | ||||
| 2023-12-31 | -0.57 | 0.46 | |||
| 2023-09-30 | -0.96 | -1.52 | |||
| 2023-06-30 | -0.74 | ||||
| 2023-03-31 | -0.65 | ||||
| 2022-12-31 | |||||
| 2022-09-30 | 0.00 | ||||
| 2022-06-30 | 0.00 | 0.00 | |||
| 2022-03-31 | 0.00 | ||||
| 2021-12-31 | -0.63 | ||||
| 2021-09-30 | -0.22 | -0.55 | |||
| 2021-06-30 | -0.18 | -0.28 | -0.24 | -0.25 | |
| 2021-03-31 | -0.18 | -0.40 | -0.25 | -0.24 | -0.21 |
| 2020-12-31 | -0.25 | -0.20 | -0.18 |
Gross Margins
- The gross margin for Healios K.K. as of June 30, 2025 is 0.73.
- The net margin for Healios K.K. as of June 30, 2025 is -7.44.
- The operating margin for Healios K.K. as of June 30, 2025 is -4.32.
- Gross Margin
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Net Margin
- The Net Margin (aka Profit Margin) is the ratio of revenue left after substracting the Net Income. It is calculated as Net Income / Revenue.
- Operating Margin
- The Operaing Margin is the ratio of revenue left after substracting the Operating Income. It is calculated as Operating Income / Revenue.
| Period End (TTM) | Gross Margin | Net Margin | Operating Margin |
| 2025-06-30 | 0.73 | -7.44 | -4.32 |
| 2025-03-31 | 0.77 | -7.56 | -5.08 |
| 2024-12-31 | 0.82 | -11.33 | -5.57 |
| 2024-09-30 | 0.87 | -10.34 | -6.06 |
| 2024-06-30 | |||
| 2024-03-31 | |||
| 2023-12-31 | |||
| 2023-09-30 | -18.76 | -20.72 | |
| 2023-06-30 | -18.76 | -20.72 | |
| 2023-03-31 | -51.64 | -53.69 | |
| 2022-12-31 | |||
| 2022-09-30 | 0.00 | 0.00 | |
| 2022-06-30 | 0.00 | 0.00 | |
| 2022-03-31 | |||
| 2021-12-31 | |||
| 2021-09-30 | |||
| 2021-06-30 | 1.00 | -145.33 | -145.21 |
| 2021-03-31 | 1.00 | -182.00 | -161.10 |
| 2020-12-31 | 1.00 | -204.15 | -154.96 |
Identifiers and Descriptors
| Central Index Key (CIK) |
